# Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC

> **NCT03243916** · NA · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** TACE plus Cyber knife

## Key facts

- **NCT ID:** NCT03243916
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-15
- **Primary completion:** 2019-07-14
- **Final completion:** 2020-07-14
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03243916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03243916, "Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03243916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*